Amgen Gets US Infliximab Nod

Amgen’s Avsola Rival To Remicade Is Its Fourth FDA-Approved Biosimilar

 
• By David Wallace
Amgen
Amgen has received an FDA approval for its Avsola version of infliximab • Source: Shutterstock

More from Biosimilars

More from Products